| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 693.38 | 566.23 | 465.22 | 425.65 |
| Other Net | 0.51 | 0.37 | 0.42 | -0.05 |
| Diluted Weighted Average Shares | 2.11 | 2.09 | 2.16 | 2.05 |
| Gain( Loss)on Saleof Assets | 0.01 | 0.01 | 0.88 | 0.01 |
| Depreciation/ Amortization | 27.99 | 13.44 | 12.36 | 12.15 |
| Operating Income | 66.49 | 64.73 | 47.86 | 40.28 |
| Net Income | 60.99 | 58.19 | 42.63 | 38.09 |
| Income Availableto Com Excl Extra Ord | 60.99 | 58.19 | 42.63 | 38.09 |
| Other Operating Expenses Total | 2.44 | 2.57 | 1.89 | 2.10 |
| Net Income Before Taxes | 79.76 | 77.09 | 57.04 | 45.57 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income After Taxes | 60.99 | 58.19 | 42.63 | 38.09 |
| Income Availableto Com Incl Extra Ord | 60.99 | 58.19 | 42.63 | 38.09 |
| Costof Revenue Total | 493.47 | 412.33 | 338.35 | 313.83 |
| Gross Profit | 266.41 | 218.63 | 174.73 | 152.10 |
| Interest Inc( Exp) Net- Non- Op Total | 12.75 | 11.99 | 7.88 | 5.33 |
| Diluted Net Income | 60.99 | 58.19 | 42.63 | 38.09 |
| DPS- Common Stock Primary Issue | 5.80 | 5.50 | 4.00 | 3.50 |
| Provisionfor Income Taxes | 18.76 | 18.90 | 14.41 | 7.48 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 60.99 | 58.19 | 42.63 | 38.09 |
| Total Revenue | 759.88 | 630.96 | 513.08 | 465.93 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 759.88 | 630.96 | 513.08 | 465.93 |
| Selling/ General/ Admin Expenses Total | 163.24 | 130.01 | 103.66 | 91.07 |
| Diluted Normalized EPS | 28.87 | 27.87 | 19.40 | 18.58 |
| Research Development | 6.25 | 7.88 | 8.95 | 6.51 |
| Diluted EPS Excluding Extra Ord Items | 28.87 | 27.88 | 19.70 | 18.58 |
| Unusual Expense( Income) | - | 0.00 | 0.01 | 0.00 |
Windlas Biotech Dividend Windlas Biotech Bonus Windlas Biotech News Windlas Biotech AGM Windlas Biotech Rights Windlas Biotech Splits Windlas Biotech Board Meetings Windlas Biotech Key Metrics Windlas Biotech Shareholdings Windlas Biotech Balance Sheet Windlas Biotech Cashflow Windlas Biotech Q1 Results Windlas Biotech Q2 Results Windlas Biotech Q3 Results Windlas Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks